SK Launches Anticoagulant Agent in Domestic Market
Published: 2005-02-02 06:56:00
Updated: 2005-02-02 06:56:00
SK Chemical and SK Pharma announced an official launching of Futhan inj. (active ingredient: nafamostat mesilate), a potent protease inhibitor originally developed by Torii Pharmaceutical of Japan, in the domestic market starting February 1st.
After obtaining a domestic marketing approval by t...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
